Home › Core › ISCC-IDs › 28CrXNENmm2EY

View ISCC-ID

Core Data

28CrXNENmm2EY
ISCC-ID - digital asset identifier
CCgAYcZe3hyks-CTLUGjd13q1cW-CD53i13RiwrCV-CRCBtuD5KVF1g
ISCC-CODE - digital asset descriptor
2QTa5N4aeSrCB2MLoPdPF4AsTjstJgcLTnd
PUBLIC-KEY or WALLET-ADDRESS of DECLARING PARTY
0
Number of times updated

Seed Metadata (Immutable)

advanced nanohybrid formulation of the sparingly soluble drug sulindac for controlled release studies

Ledger Reference

coblo
Source Ledger/Blockchain
259591
N-th ISCC Decleration on source ledger
42f06cc2e2aebe1e78797408c7cc888b81fe16ec803f32ef896c6fececb116d7
Hash of block that includes the ISCC-DECLARATION
68dc70d86da938a1cd2e79799c1c7911293d7722681a2e9a1cec15730c3217ec
Hash of transaction that includes the ISCC-DECLERATION
0
Output index that includes ISCC-DECLERATION (UTXO based chains)

Mutable Metadata

[{"data": {"name": "ADVANCED NANOHYBRID FORMULATION OF THE SPARINGLY SOLUBLE DRUG SULINDAC FOR CONTROLLED RELEASE STUDIES", "@type": "ScholarlyArticle", "genre": "journal-article", "author": [{"name": "KEIJI MINAGAWA", "@type": "Person"}, {"name": "MOHAMED R. BERBER", "@type": "Person"}, {"name": "INAS H. HAFEZ", "@type": "Person"}, {"name": "TAKESHI MORI", "@type": "Person"}, {"name": "MASAMI TANAKA", "@type": "Person"}], "@context": "http://schema.org/", "encoding": [{"@type": "MediaObject", "contentUrl": "https://www.worldscientific.com/doi/pdf/10.1142/S2010194512003856", "encodingFormat": "application/pdf"}], "publisher": {"name": "World Scientific Pub Co Pte Lt", "@type": "Organization"}, "identifier": [{"@type": "PropertyValue", "value": "10.1142/s2010194512003856", "propertyID": "DOI"}, {"@type": "PropertyValue", "value": "CCgAYcZe3hyks-CTLUGjd13q1cW-CD53i13RiwrCV-CRCBtuD5KVF1g", "propertyID": "ISCC"}], "datePublished": "2012-01-01"}, "schema": "schema.org", "mediatype": "application/ld+json"}]
Close